SMNR (Semnur Pharmaceuticals) Net Margin %: 0.00% (As of Mar. 2026)


SMNR Semnur Pharmaceuticals Inc SMNR
8 GF Score
Price $0.71
View Full Analysis

What is Semnur Pharmaceuticals Net Margin %?

Semnur Pharmaceuticals SMNR +9.23% 8 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates SMNR with a GF Score™ of 8/100. Among 938 Biotechnology companies, Semnur Pharmaceuticals ranks worse than 106609.7% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Semnur Pharmaceuticals's Net Income for the three months ended in Mar. 2026 was $-4.58 Mil. Semnur Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Semnur Pharmaceuticals's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Semnur Pharmaceuticals's Net Margin % or its related term are showing as below:


SMNR's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.09
* Ranked among companies with meaningful Net Margin % only.

Semnur Pharmaceuticals  (OTCPK:SMNR) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Semnur Pharmaceuticals Net Margin % Related Terms

Semnur Pharmaceuticals Net Margin % Historical Data

* Premium members only.

The historical data trend for Semnur Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Semnur Pharmaceuticals Net Margin % Chart

Semnur Pharmaceuticals Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Net Margin %
0.00 0.00 0.00 0.00

Semnur Pharmaceuticals Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

SMNR vs CNTB, ENLV, MENS: Net Margin % Comparison

For the Biotechnology subindustry, Semnur Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Semnur Pharmaceuticals Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Semnur Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Semnur Pharmaceuticals's Net Margin % falls into.


SMNR
8GF Score
Semnur Pharmaceuticals Inc SMNR
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Semnur Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Semnur Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-160.416/0
= %

Semnur Pharmaceuticals's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-4.576/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Semnur Pharmaceuticals (SMNR) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Semnur Pharmaceuticals and its competitors. According to the industry distribution chart, Semnur Pharmaceuticals ranks #999999 out of 938 companies in the Biotechnology industry.
Is Semnur Pharmaceuticals' Net Margin % too high?
Semnur Pharmaceuticals' current Net Margin % is 0.00%. Based on the distribution chart, Semnur Pharmaceuticals ranks #999999 out of 938 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Semnur Pharmaceuticals has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Semnur Pharmaceuticals' Net Margin % compare to CNTB and ENLV?
According to the Biotechnology industry distribution chart, Semnur Pharmaceuticals ranks #999999 out of 938 companies for Net Margin %. This places Semnur Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Semnur Pharmaceuticals and its competitors. Semnur Pharmaceuticals's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Semnur Pharmaceuticals stock overvalued right now?
Semnur Pharmaceuticals (SMNR) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Semnur Pharmaceuticals' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Semnur Pharmaceuticals (SMNR), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Semnur Pharmaceuticals Business Description

Address 960 San Antonio Road, Palo Alto, CA, USA, 94303
Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its main product candidate, SP-102 (10 mg, dexamethasone sodium phosphate viscous gel), is being developed as a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe LRP (also known as sciatica), containing no preservatives, surfactants, solvents, or particulates.
8GF Score

Get the complete analysis for SMNR

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.71
Price